Shandong Rike Chemical Co.,LTD.

SZSE:300214 Stock Report

Market Cap: CN¥2.6b

Shandong Rike ChemicalLTD Past Earnings Performance

Past criteria checks 0/6

Shandong Rike ChemicalLTD's earnings have been declining at an average annual rate of -23.3%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 3.7% per year.

Key information

-23.3%

Earnings growth rate

-24.3%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate3.7%
Return on equity-2.0%
Net Margin-1.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Earnings Troubles May Signal Larger Issues for Shandong Rike ChemicalLTD (SZSE:300214) Shareholders

May 03
Earnings Troubles May Signal Larger Issues for Shandong Rike ChemicalLTD (SZSE:300214) Shareholders

Recent updates

Revenues Working Against Shandong Rike Chemical Co.,LTD.'s (SZSE:300214) Share Price

Dec 24
Revenues Working Against Shandong Rike Chemical Co.,LTD.'s (SZSE:300214) Share Price

Shandong Rike ChemicalLTD (SZSE:300214) Might Be Having Difficulty Using Its Capital Effectively

Aug 28
Shandong Rike ChemicalLTD (SZSE:300214) Might Be Having Difficulty Using Its Capital Effectively

Subdued Growth No Barrier To Shandong Rike Chemical Co.,LTD.'s (SZSE:300214) Price

Jun 03
Subdued Growth No Barrier To Shandong Rike Chemical Co.,LTD.'s (SZSE:300214) Price

Earnings Troubles May Signal Larger Issues for Shandong Rike ChemicalLTD (SZSE:300214) Shareholders

May 03
Earnings Troubles May Signal Larger Issues for Shandong Rike ChemicalLTD (SZSE:300214) Shareholders

Shandong Rike ChemicalLTD (SZSE:300214) Will Be Hoping To Turn Its Returns On Capital Around

Feb 28
Shandong Rike ChemicalLTD (SZSE:300214) Will Be Hoping To Turn Its Returns On Capital Around

Revenue & Expenses Breakdown

How Shandong Rike ChemicalLTD makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300214 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,048-5011730
30 Jun 242,734-1611133
31 Mar 242,5615810236
31 Dec 232,538858441
30 Sep 232,5351188022
31 Mar 232,6071338346
01 Jan 232,7601968340
30 Sep 222,9512178249
31 Mar 222,9302338527
01 Jan 222,7731908724
30 Sep 212,5461605628
30 Jun 212,4241695317
31 Mar 212,3591895515
31 Dec 202,2752077014
30 Sep 202,37724112912
30 Jun 202,44122514211
31 Mar 202,40720815111
31 Dec 192,42017814312
30 Sep 192,26613413012
30 Jun 192,13911512711
31 Mar 191,8849411310
31 Dec 181,56910311610
30 Sep 181,58310411324
30 Jun 181,68911711422
31 Mar 181,89412112519
31 Dec 172,1039512517
30 Sep 171,992911230
30 Jun 171,784721230
31 Mar 171,631731190
31 Dec 161,547801190
30 Sep 161,431921130
30 Jun 161,3861021130
31 Mar 161,4251001200
31 Dec 151,4231071200
30 Sep 151,466971270
30 Jun 151,477801230
31 Mar 151,385641150
31 Dec 141,305531070
30 Sep 141,216431070
30 Jun 141,077451010
31 Mar 141,008551030
31 Dec 131,002551080

Quality Earnings: 300214 is currently unprofitable.

Growing Profit Margin: 300214 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300214 is unprofitable, and losses have increased over the past 5 years at a rate of 23.3% per year.

Accelerating Growth: Unable to compare 300214's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300214 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.7%).


Return on Equity

High ROE: 300214 has a negative Return on Equity (-2.01%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 15:43
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Rike Chemical Co.,LTD. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiang ZhangChangjiang Securities Co. LTD.
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)
Li HuiCitic Securities Co., Ltd.